Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Kala Pharma Says US FDA OKs EYSUVIS 0.25% For Short-term Treatment Of Signs And Symptoms Of Dry Eye


RTTNews | Oct 27, 2020 07:18AM EDT

07:18 Tuesday, October 27, 2020 (RTTNews) - Kala Pharma Says US FDA OKs EYSUVIS 0.25% For Short-term Treatment Of Signs And Symptoms Of Dry Eye

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2020 RTTNews.com. All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC